Reduced SH3RF3 May Protect Against Alzheimer's Disease by Lowering Microglial Pro‐Inflammatory Responses via Modulation of JNK and NFkB Signaling
Glia · 2026
DOI: 10.1002/glia.70165 ↗Kurz gefasst
Fachartikel in der Zeitschrift Glia, 2026. Verfasst von Ronak Patel und 13 weiteren Autor:innen. Beteiligte Einrichtung: Taub Institute for Research on Alzheimer's Disease and the Aging Brain, Columbia University Irving Medical Center (CUIMC), New York, New York, USA. Hauptthemen laut MEDLINE: Microglia, Alzheimer Disease, NF-kappa B. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 94 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIA NIH HHS, The Thompson Family Foundation, BrightFocus Foundation.
Themen: Demenz
Abstract (Originalsprache)
Understanding how high‐risk individuals are protected from Alzheimer's disease (AD) may illuminate potential therapeutic targets. We identified protective genetic variants in SH3RF3 / POSH2 that delayed the onset of AD among individuals carrying the PSEN1 G206A mutation. SH3RF3 acts as a JNK pathway scaffold and activates NFκB signaling. While the effects of SH3RF3 knockdown in human neurons were subtle, including decreased pTau S422, knockdown in human microglia significantly reduced inflammatory cytokines in response to either a viral mimic or oAβ42. This was associated with reduced activation of JNK and NFκB pathways in response to these stimuli. Pharmacological inhibition of JNK or NFκB signaling phenocopied SH3RF3 knockdown. We also found PSEN1 G206A microglia had a reduced inflammatory response to oAβ42. Thus, further reduction of microglial inflammatory responses in PSEN1 G206A mutant carriers by protective variants in SH3RF3 might reduce the link between amyloid and neuroinflammation to subsequently delay the onset of AD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Taub Institute for Research on Alzheimer's Disease and the Aging Brain, Columbia University Irving Medical Center (CUIMC), New York, New York, USA.
- Department of Neurology, CUIMC, New York, New York, USA.
- Department of Pathology and Cell Biology, CUIMC, New York, New York, USA.
- East Side Community School, New York, New York, USA.
- G.H. Sergievsky Center, CUIMC, New York, New York, USA.
- Department of Internal Medicine, Geriatric Division, University of Puerto Rico School of Medicine, San Juan, Puerto Rico, USA.
ORCID-Profile: Christopher L Cardona, Joseph H Lee, Andrew A Sproul
Förderung
- NIA NIH HHS
- The Thompson Family Foundation
- BrightFocus Foundation
- Henry and Marilyn Taub Foundation
- National Institute on Aging
Zitieren
APA
Patel, R., Cheng, R., Cardona, C. L., Angeles, E., Singh, G., Miller, S., Ashok, A., Teich, A. F., Piriz, A., Maldonado, A., Jiménez-Velázquez, I. Z., Mayeux, R., Lee, J. H., & Sproul, A. A. (2026). Reduced SH3RF3 May Protect Against Alzheimer's Disease by Lowering Microglial Pro‐Inflammatory Responses via Modulation of JNK and NFkB Signaling. Glia. https://doi.org/10.1002/glia.70165
Vancouver
Patel R, Cheng R, Cardona CL, Angeles E, Singh G, Miller S, et al. Reduced SH3RF3 May Protect Against Alzheimer's Disease by Lowering Microglial Pro‐Inflammatory Responses via Modulation of JNK and NFkB Signaling. Glia. 2026. doi:10.1002/glia.70165
BibTeX
@article{Patel2026,
author = {Patel, Ronak and Cheng, Rong and Cardona, Christopher L and Angeles, Ellen and Singh, Gunjandeep and Miller, Sabrina and Ashok, Archana and Teich, Andrew F and Piriz, Angel and Maldonado, Aleyda and Jiménez-Velázquez, Ivonne Z and Mayeux, Richard and Lee, Joseph H and Sproul, Andrew A},
title = {Reduced SH3RF3 May Protect Against Alzheimer's Disease by Lowering Microglial Pro‐Inflammatory Responses via Modulation of JNK and NFkB Signaling},
journal = {Glia},
year = {2026},
doi = {10.1002/glia.70165}
}
EUVIMED